Literature DB >> 12713676

Breath markers of oxidative stress in patients with unstable angina.

Michael Phillips1, Renee N Cataneo, Joel Greenberg, Richard Grodman, Manuel Salazar.   

Abstract

Cardiac chest pain is accompanied by oxidative stress, which generates alkanes and other volatile organic compounds (VOCs). These VOCs are excreted in the breath and could potentially provide a rational diagnostic marker of disease. The breath methylated alkane contour (BMAC), a 3-dimensional surface plot of C4-C20 alkanes and monomethylated alkanes, provides a comprehensive set of markers of oxidative stress. In this pilot study, we compared BMACs in patients with unstable angina pectoris and in healthy volunteers. Breath VOCs were analyzed in 30 patients with unstable angina confirmed by coronary angiography and in 38 age-matched healthy volunteers with no known history of heart disease (mean age +/- SD, 62.7 +/- 12.3 years and 62.5 +/- 10.0, not significant). BMACs in both groups were compared to identify the combination of VOCs that provided the best discrimination between the 2 groups. Forward stepwise entry discriminant analysis selected 8 VOCs to construct a predictive model that correctly classified unstable angina patients with sensitivity of 90% (27 of 30) and specificity of 73.7% (28 of 38). On cross-validation, sensitivity was 83.3% (25 of 30) and specificity was 71.1% (27 of 38). We conclude that the breath test distinguished between patients with unstable angina and healthy control subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713676     DOI: 10.1097/01.hdx.0000061701.99611.e8

Source DB:  PubMed          Journal:  Heart Dis        ISSN: 1521-737X


  8 in total

1.  Bronchoscopically obtained volatile biomarkers in lung cancer.

Authors:  Kaid Darwiche; Joerg Ingo Baumbach; Urte Sommerwerck; Helmut Teschler; Lutz Freitag
Journal:  Lung       Date:  2011-10-04       Impact factor: 2.584

2.  Halitosis: a new definition and classification.

Authors:  M Aydin; C N Harvey-Woodworth
Journal:  Br Dent J       Date:  2014-07-11       Impact factor: 1.626

3.  Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.

Authors:  Anton Amann; Pawel Mochalski; Vera Ruzsanyi; Yoav Y Broza; Hossam Haick
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

4.  Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine.

Authors:  Patrick A Gladding; Andrew Cave; Mehran Zareian; Kevin Smith; Jagir Hussan; Peter Hunter; Folarin Erogbogbo; Zoraida Aguilar; David S Martin; Eugene Chan; Margie L Homer; Abhijit V Shevade; Mohammad Kassemi; James D Thomas; Todd T Schlegel
Journal:  J Pers Med       Date:  2013-08-21

Review 5.  From blood to breath: New horizons for esophageal cancer biomarkers.

Authors:  Roger Yazbeck; Simone E Jaenisch; David I Watson
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

6.  Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.

Authors:  Faisal Kamal; Sacheen Kumar; Michael R Edwards; Kirill Veselkov; Ilaria Belluomo; Tatiana Kebadze; Andrea Romano; Maria-Belen Trujillo-Torralbo; Tasnim Shahridan Faiez; Ross Walton; Andrew I Ritchie; Dexter J Wiseman; Ivan Laponogov; Gavin Donaldson; Jadwiga A Wedzicha; Sebastian L Johnston; Aran Singanayagam; George B Hanna
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

7.  Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension.

Authors:  J K Mansoor; Edward S Schelegle; Cristina E Davis; William F Walby; Weixiang Zhao; Alexander A Aksenov; Alberto Pasamontes; Jennifer Figueroa; Roblee Allen
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 8.  Advances in Mid-Infrared Spectroscopy-Based Sensing Techniques for Exhaled Breath Diagnostics.

Authors:  Ramya Selvaraj; Nilesh J Vasa; S M Shiva Nagendra; Boris Mizaikoff
Journal:  Molecules       Date:  2020-05-09       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.